A recent workforce study of rheumatology in the US suggests that during the next several decades, the demand for rheumatology services will outstrip the supply of rheumatologists. Midlevel providers such as nurse practitioners and physician assistants may be able to alleviate projected shortages. Methods. We administered a nationwide survey of midlevel providers during 2012. Invitations with the survey were sent with one followup reminder. The survey contained questions regarding demographics, training, level of practice independence, responsibilities, drug prescribing, use of objective outcome measures, and knowledge and use of treat-to-target (TTT) strategies. Results. The invitation was sent to 482 eligible midlevel providers via e-mail and 90 via US mail. We received a total of 174 responses (30%). The mean age was 46 years and 83% were women. Nearly 75% had <10 years of experience and 53% had received formal training in rheumatology. Almost two-thirds reported having their own panel of patients. The top 3 practice responsibilities described were performing patient education (99%), adjusting medication doses (98%), and conducting physical examinations (97%). More than 90% felt very or somewhat comfortable diagnosing rheumatoid arthritis (RA) and a similar percentage prescribed disease-modifying antirheumatic drugs. Three-quarters reported using disease activity measures for RA and 56% reported that their practices used TTT strategies. Conclusion. Most respondents reported that they had substantial patient care responsibilities, used disease activity measures for RA, and incorporated TTT in their practice. These data suggest midlevel providers may help to reduce shortages in the rheumatology workforce and conform with recommendations to employ TTT strategies in RA treatment.
INTRODUCTION
A recent workforce study of rheumatology in the US suggests that during the next several decades, the demand for rheumatologists will outstrip the supply (1) . Apart from improving prevention of rheumatic diseases, potential so-lutions to this problem include increasing the supply of rheumatologists and/or improving efficiency within the rheumatology practice. Therefore, it is incumbent upon the rheumatology profession to increase the supply of rheumatologists or providers with rheumatic disease expertise. Given the American College of Rheumatology's prediction that the number of rheumatologists practicing in the US will start to decline in 2016 (1) , it becomes important to consider an increased role for midlevel providers, such as nurse practitioners (NPs) and physician assistants (PAs), in rheumatology practices (2) .
Midlevel providers have played an important role in rheumatology for over a decade (3) . In addition, the use of midlevel providers has grown in many areas of medical and surgical practice and is predicted to continue to grow with reforms in health care (4) . Changes proposed in the recently enacted Affordable Care Act include a more prominent role for midlevel providers in a team-based setting, especially within patient-centered medical homes (5) . Before rheumatologists determine how best to employ midlevel providers, it would be useful to gain a greater understanding of their current roles and responsibilities. The most recent survey, conducted in 2007 among PAs, suggested that their practice responsibilities include drug prescribing, joint injections, and research (6) .
Several studies have suggested that midlevel providers have a high level of satisfaction with the career, but little formal training. Rheumatology practice is changing rapidly, with greater treatment options and a greater emphasis on aggressive treatment strategies, such as treat-to-target (TTT). With this emphasis on a changing practice style, requiring better access (i.e., more frequent visits in person and by telephone) and frequent treatment changes, it is unclear whether the roles of NPs and PAs have adapted.
Because of the potential growing importance of NPs and PAs, we have conducted an updated survey of these providers working in the US rheumatology field, focusing on their roles in the care of patients with rheumatoid arthritis (RA). This descriptive study was based on the hypothesis that NPs and PAs have broad responsibilities in rheumatology practice that might provide opportunities for alleviating projected workforce shortages and for facilitating use of TTT in rheumatology practice.
MATERIALS AND METHODS
Study participants. We collaborated with the Association of Rheumatology Health Professionals (ARHP) and the Society of Physician Assistants in Rheumatology (SPAR). Both organizations e-mailed a link to the survey to NPs and PAs who work in rheumatology practices in the US. The survey was also sent via US mail to some SPAR members who had no active e-mail addresses. The only requirement for survey participation was that respondents were actively working with a rheumatologist. The survey and protocol were approved by the appropriate institutional review board.
Survey. The majority of the questionnaire focused on participants' demographics, training, practice environment, level of independence, practice responsibilities, use
Significance & Innovations
• Nurse practitioners and physician assistants in US rheumatology practices reported substantial patient care responsibilities, used disease activity measures for rheumatoid arthritis (RA), and incorporated treat-to-target (TTT) strategies in their practice.
• Midlevel providers may help to reduce shortages in the rheumatology workforce and to conform with recommendations to employ TTT strategies in RA treatment. The secure online questionnaire data disseminated via e-mail were collected and managed using an electronic data capture tool hosted at Brigham and Women's Hospital. Both the ARHP and SPAR sent out a link to the survey accompanied by a short paragraph explaining the study and provided our contact information should participants have any questions. We administered the US mailing ourselves, which included similar information accompanying a paper survey and return envelope with postage included. A single additional wave of followup was sent to the ARHP and SPAR e-list recipients as well as the SPAR mailing list 2-3 weeks after the first mailing.
Statistical analysis.
The primary goal of this study was to gain a better understanding of the current roles of midlevel providers in rheumatology and assess their capabilities in independent practice. Secondarily, we were interested in their ability to implement TTT strategies. Analyses were primarily descriptive. Survey responses were stratified and compared by NP and PA certification. Means, medians, and percentages were calculated and compared using appropriate statistical tests. All analyses were conducted using SAS 9.2.
RESULTS
We contacted approximately 572 NPs and PAs; precise counts are difficult because there was overlap on the lists and we did not have access to all lists to compare membership. From this pool of recipients, we received 204 questionnaires, but 30 were incomplete. The final sample was 174 unique completed questionnaires for an approximate 30% response rate. 1110
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Respondents were similar in number between NPs and PAs ( Table 1 ). PAs were slightly younger (mean age 42 years) than NPs (mean age 49 years; P Ͻ 0.0001). Ninetyfour percent of NPs and 74% of PAs were women (P Ͻ 0.001). The duration of years in any practice was similar for NPs and PAs. There was also a fairly uniform distribution in each category, with approximately one-quarter each reporting 0 -5 years, 6 -10 years, 11-15 years, and Ն16 years in practice.
Almost three-quarters of both NPs and PAs reported Յ10 years of rheumatology practice. Only half described having specific rheumatology training prior to joining a rheumatology practice. The majority described on-the-job training as well as attending the ARHP course. Approximately three-quarters of all respondents work full time and approximately two-thirds described having their own panel of patients. The mean panel size of those reporting their own panels was 153 patients.
Regarding level of independence when seeing patients, few respondents described the rheumatologist assisting with all patients, approximately half described the rheumatologist assisting when needed, and the remainder described the rheumatologist assisting rarely or never ( Table 2 ). The level of independence did not vary by age, sex, or certification of the midlevel provider, or by the number of years since certification, the number of years in rheumatology, or rheumatology training. Respondents reporting greater confidence making the diagnosis of RA were more likely to report never seeing patients with the rheumatologist.
We also examined the DMARD prescribing practices (Figure 1 ). Almost all respondents reported prescribing both nonbiologic DMARDs and biologic DMARDs, with a slightly higher percentage prescribing nonbiologic than biologic DMARDs. They reported more frequently initiating prescriptions than modifying doses for all medications. We did not find an association between DMARD prescribing patterns and years in rheumatology practice (data not shown).
Respondents reported a wide variety of practice activities ( Table 3 ). The most frequently reported were performing patient education, adjusting medication doses, conducting physical examinations, general treatment, starting patients on medications, and interpreting and delivering test results. Other common roles were performing intake assessments, performing intraarticular injections, giving medication injections, and interpreting bone mineral density tests. There were some specific differences noted in the roles played by NPs and PAs, with NPs more likely to manage an infusion clinic (31% versus 15%; P ϭ 0.01) and PAs more likely to interpret bone mineral density tests (75% versus 51%; P ϭ 0.001). In the context of the patient visit, respondents frequently conducted urgent visits, as well as initial assessments and followup visits. There were no clear differences observed by the years in rheumatology practice (data not shown).
Finally, we examined the use of RA disease activity measures and TTT strategies. We asked respondents if they were familiar with TTT. Seventy-five percent (n ϭ 130) responded affirmatively and 56% (n ϭ 98) reported that their practice used TTT.
Consistent use of an RA disease activity measure was reported by 73% of respondents (Table 4 ). Respondents reported using the Disease Activity Score (29%), the Clinical Disease Activity Index (17%), the Simplified Disease Activity Index (8%), the Routine Assessment of Patient Index Data (31%), and a patient global arthritis activity index (34%). Reported use of an RA disease activity mea- sure did not differ among those who did and those who did not use TTT (P ϭ 0.64).
DISCUSSION
Several trends are likely to raise the importance of NPs and PAs in rheumatology practice. While some information exists on NPs and PAs in rheumatology, more current information may help to better understand how to optimize their roles in future practice. We conducted a written survey of NPs and PAs through 2 important practice organizations, the ARHP and the SPAR. The majority of respondents described Յ10 years of experience in rheumatology and only half had received formal training in rheumatology. However, they reported a high level of independence and broad responsibilities in practice, including DMARD prescribing. Most reported using RA disease activity measures and approximately half reported that their practices used TTT strategies.
Respondents reported similar roles and responsibilities found in prior research (6) . In addition, we found a high percentage of respondents who reported prescribing DMARDs. Similar to what has been reported in the past, most respondents noted that their rheumatology training is on the job. The relationship between reported confidence in diagnosing RA and never seeing patients with the rheumatologist is unclear. On the one hand, NP and PA confidence in diagnosing RA may result in the rheumatologist never seeing patients with these providers. Conversely, it may be that rheumatologists who supervise NPs and PAs less rigorously rationalize this behavior by explaining to the NP or PA that their ability obviates seeing patients together.
These results are important on several levels. First, the substantial independence and broad responsibilities of midlevel providers suggest that they should be able to help extend the rheumatology workforce. One rheumatologist would likely be able to supervise several NPs and/or PAs, multiplying the availability of rheumatic disease expertise. This change in the rheumatology workforce would require several steps: NPs and PAs would need to be 
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Solomon et al recruited into rheumatology, appropriate training would need to be offered, and rheumatology practices would need to learn how to best integrate them into the workflow cost effectively. If these steps are successful, this may help to alleviate projected shortfalls in the rheumatology workforce. Integration of midlevel providers has been successfully accomplished in primary care through easing scope of practice regulations, team-based workforce training, and more formal recruitment from health professional schools. Second, midlevel providers could facilitate efforts of rheumatologists to treat RA earlier and more aggressively using the TTT paradigm. Approximately 78% of the study sample indicated that they knew of TTT and three-quarters of that subset reported using it in practice, demonstrating that a strong base already exists upon which to expand. Utilizing NPs and PAs may allow for more rapid followup visits and improve throughput in a rheumatology practice, eliminating some of the current difficulties and constraints of disseminating TTT in typical practice. In addition, midlevel providers are often more comfortable following a treatment algorithm and have been key in achieving TTT in other clinical areas, such as hypertension, hyperlipidemia, anticoagulation for thromboembolic event prophylaxis, and control of diabetes mellitus (7) (8) (9) .
However, the lack of reported formal training may be a hindrance to recruiting NPs and PAs into rheumatology and likely slows on-the-job training. Rheumatology organizations may consider working with schools of nursing and PA programs to incorporate rheumatology into the curriculum. Rheumatology preceptorships for midlevel providers would also likely be an important recruiting method.
Several limitations to our survey are important to consider. Although 30 -35% of recruitment is typical in an e-mail survey (10), it is not optimal. We did not have access to all of the e-mail and street addresses. Therefore, we were limited in the number of attempts to recruit subjects. Also, the ARHP contacted a large portion of the potential respondents. This may have introduced some bias. Finally, as with any survey, it is unclear how well responses reflect the reality of practice.
In conclusion, we found that midlevel providers in rheumatology have many practice responsibilities and function as semi-independent clinicians with their own panels of patients. Most are comfortable with RA diagnosis and treatment and use of disease activity measures. The rheumatology profession should strongly consider methods for increasing the numbers of NPs and PAs in rheumatology practice to both enhance access and provide a workforce that can meet evolving practice needs. This will require a strategic investment by rheumatology organizations, but will likely allow rheumatologists to provide high-quality care in the evolving health care delivery system in which midlevel providers play more prominent roles.
